Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion type Assertion NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_head.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion description "[NRAS and KRAS mutated tumors did not show significant differences in terms of clinical and pathological characteristics, except for a lower prevalence of mucinous histology (p?=?0.012) and lung metastases (p?=?0.012) among NRAS mutated tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_provenance.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion evidence source_evidence_literature NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_provenance.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion SIO_000772 24806288 NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_provenance.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion wasDerivedFrom befree-2016 NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_provenance.
- NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_assertion wasGeneratedBy ECO_0000203 NP1180330.RAlR9jCck1_PwU1suhQX22UQK-sNCdXfNEbXtken-Ky-Q130_provenance.